Shots:
- The company has submitted a 510(k) application to the US FDA for its proprietary AI-assisted module designed for use with CapsoCam Plus
- The CapsoCam Plus capsule endoscopy system is designed to visualize small bowel mucosa and detect abnormalities in adults and children (age ≥ 2 yrs)
- The reading tool is expected to improve the detection of clinically significant pathology and reduce clinician review time. US commercialization is planned following FDA clearance
Ref: GlobeNewswire | Image: CapsoVision | Press Release
Related News: KORU Medical Systems Seeks FDA Clearance for FreedomEDGE System to Deliver Phesgo in HER2+ Breast Cancer Patients
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
